GWS
FOLD

Glassman Wealth Services’s Amicus Therapeutics FOLD Stock Holding History

Glassman Wealth Services’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-23
Closed – – 1782
2022
Q1 		$0 Sell
23
-70
-75% -$656 ﹤0.01% 1736
2021
Q4 		$1K Buy
93
+15
+19% +$167 ﹤0.01% 1373
2021
Q3 		$1K Hold
78
– – ﹤0.01% 1348
2021
Q2 		$1K Sell
78
-36
-32% -$351 ﹤0.01% 1288
2021
Q1 		$1K Buy
114
+6
+6% +$93 ﹤0.01% 1250
2020
Q4 		$2K Hold
108
– – ﹤0.01% 1064
2020
Q3 		$2K Hold
108
– – ﹤0.01% 994
2020
Q2 		$2K Buy
108
+53
+96% +$646 ﹤0.01% 852
2020
Q1 		$1K Sell
55
-2
-4% -$19 ﹤0.01% 875
2019
Q4 		$1K Buy
+57
New +$522 ﹤0.01% 917

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Glassman Wealth Services's FOLD Position: Q2 2022 in Review

Glassman Wealth Services sold out of Amicus Therapeutics (FOLD) in Q2 2022, closing a stake of 23 shares.

Glassman Wealth Services first reported a position in FOLD in Q4 2019 and held it in 10 quarters. The position peaked at $2K in Q4 2020. 212 funds tracked by Wall St. Rank hold FOLD as of Q2 2022.

  • Glassman Wealth Services reported no remaining Amicus Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Glassman Wealth Services sold 23 Amicus Therapeutics shares in Q2 2022.
  • Glassman Wealth Services first reported a position in Amicus Therapeutics in Q4 2019 and held it in 10 quarters.
  • Glassman Wealth Services's Amicus Therapeutics position peaked at $2K in Q4 2020.
  • 212 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2022.

Based on Glassman Wealth Services's 13F filing for Q2 2022, filed 4 Aug 2022.